You just read:

Daiichi Sankyo Presents Updated Phase 1 Data for U3-1402 in Patients with HER3-Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS)

News provided by

Daiichi Sankyo Company, Limited

Dec 05, 2018, 18:00 ET